Cardio-oncology Related to Heart Failure, An Issue of Heart Failure Clinics, 1e (The Clinics: Internal Medicine). Dieser Artikel ist nicht verfügbar.Cardio-oncology Related to Heart Failure, An Issue of Heart Failure Clinics, 1e (The Clinics: Internal Medicine)

This issue of the Heart Failure Clinics of North America, guest edited by Drs. Daniel Lenihan and Douglas Sawyer, will cover several aspects of Cardio-oncology Related to Heart Failure. Subjects discussed in the volume include, but are not limited to: Proteasome Inhibitors as a potential cause of Heart Failure; EGFR target based therapy; Amyloidosis; How to manage Heart Failure in a patient with cancer; Advanced HF/Txp; Epidemiology and common risk factors; Pediatric Considerations; Alternative biomarkers for combined biology; How to develop a Cardio-Oncology Clinic; and How to structure a Cardio-Oncology fellowship program, among others.

Douglas B. Sawyer is a cardiologist and clinician-investigator whose work in basic and translational research has focused on mechanisms by which the heart maintains cardiac function and recovers after injury. Formerly Chief of Cardiology at Vanderbilt University, and Chief of Cardiac Services and Physician Leader of the Cardiovascular Service Line at Maine Medical Center, USA, Dr. Sawyer has more recently served as the Chief Academic Officer for MaineHealth. He is a Professor of Medicine at Tufts University School of Medicine and serves as the Academic Dean for the TUSM Maine Track. His clinical interests include Cardiovascular Disease, Heart Failure, Clinical and Translational Research. Dr Sawyer is a Fellow of the American College of Cardiology and of the Heart Failure Society of America. He is an elected member of the Association of University Cardiologists and the American Society for Clinical Investigation.